Advertisement

Topics

Human medicines European public assessment report (EPAR): M-M-RVaxPro, measles, mumps and rubella vaccine (live), Revision: 19, Authorised

12:24 EDT 21 Jun 2017 | European Medicines Agency

This article has expired, however you can still download the PDF.
Preview:
...

Other Sources for this Article

Original Article: Human medicines European public assessment report (EPAR): M-M-RVaxPro, measles, mumps and rubella vaccine (live), Revision: 19, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): M-M-RVaxPro, measles, mumps and rubella vaccine (live), Revision: 19, Authorised"

Advertisement
Quick Search
Advertisement
Advertisement